Kairos Pharma cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 9 quarters of results from Sep 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow StatementCash Flow | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | -0.31M | -1.12M | -0.32M | -0.25M | -1.05M | -0.98M | -1.26M | -1.42M | |
| Depreciation, Depletion & Amortization | |||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | 0.04M | ||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.01M | 0.03M | 0.02M | 0.12M | |||||
| Other non-cash itemsOther Non-Cash | 0.59M | ||||||||
| Change in Working Capital | |||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.20M | 0.31M | 0.02M | -0.19M | 0.26M | -0.19M | -0.13M | ||
| Change in Other Operating AssetsOther Assets Change | -0.01M | 0.01M | 0.00M | 1.51M | 0.87M | -0.64M | 0.69M | ||
| Other Working Capital ChangesOther WC Changes | 0.01M | -0.01M | 0.00M | -1.51M | -0.87M | 0.64M | -0.69M | ||
| Cash from OperationsCash from Ops. | 0.07M | 0.04M | -0.17M | -2.02M | -1.80M | -0.71M | -0.81M | ||
| Financing Activities | |||||||||
| Debt Issuance and Repayment | |||||||||
| Long-Term Debt IssuancesLT Debt Issuance | 0.04M | ||||||||
| Non-Current Debt | 0.04M | ||||||||
| Net Debt Issuances and RepaymentsNet Debt Issuance | 0.04M | ||||||||
| Change in Capital Stock | |||||||||
| Common Stock IssuedStock Issued | 3.06M | ||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 3.06M | ||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 3.06M | ||||||||
| Other financing activitiesOther financing | -0.07M | -0.09M | 0.05M | -0.35M | |||||
| Cash from Financing ActivitiesCash from Financing | -0.07M | -0.09M | 0.15M | 5.22M | -0.14M | 3.06M | 0.22M | ||
| Additional items | |||||||||
| Change in Cash | -0.01M | -0.05M | -0.02M | 3.20M | -1.95M | 2.34M | -0.58M | ||
| Ending Cash Balance | 0.10M | 0.09M | 0.04M | 0.02M | 3.22M | 1.27M | 3.62M | 3.03M | 4.49M |
| Free Cash FlowFCF | 0.07M | 0.04M | -0.17M | -2.02M | -1.80M | -0.71M | -0.81M | ||
| Net Cash FlowNCF | -0.01M | -0.05M | -0.02M | 3.20M | -1.95M | 2.34M | -0.58M |
Pull Kairos Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=KAPA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "KAPA", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=KAPA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();